Viewing StudyNCT00055237



Ignite Creation Date: 2024-05-05 @ 11:28 AM
Last Modification Date: 2024-10-26 @ 9:08 AM
Study NCT ID: NCT00055237
Status: COMPLETED
Last Update Posted: 2017-09-06
First Post: 2003-02-21

Brief Title: Bevacizumab to Treat Kaposis Sarcoma in HIV-Positive and HIV-Negative Patients
Sponsor: National Cancer Institute NCI
Organization: National Institutes of Health Clinical Center CC

Key Dates - Follows AllAPIJSON File Order

Start Date: 2003-02-26
Start Date Type: ACTUAL
Primary Completion Date: 2010-03-15
Primary Completion Date Type: ACTUAL
Completion Date: 2010-03-15
Completion Date Type: ACTUAL
First Submit Date: 2003-02-21
First Submit QC Date: February 20 2003
Study First Post Date: 2003-02-21
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2012-07-26
Results First Post Date Type: ESTIMATED
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2017-08-07
Last Update Post Date: 2017-09-06
Last Update Post Date Type: ACTUAL